Identification of Potential Biomarkers and Immune Cell Signatures in COVID-19 Myocarditis Through Bioinformatic Analysis

Yongfei Song; Xiaofei Wang; Dongdong Tong; Xiaoyan Huang; Xiaojun Jin; Chuanjing Zhang; Jianhui Liu; Bo Guo; Chen Huang; Jiangfang Lian

doi:10.1155/crp/2349610

Cardiology Research and Practice (Jan 2025)

Identification of Potential Biomarkers and Immune Cell Signatures in COVID-19 Myocarditis Through Bioinformatic Analysis

Yongfei Song,
Xiaofei Wang,
Dongdong Tong,
Xiaoyan Huang,
Xiaojun Jin,
Chuanjing Zhang,
Jianhui Liu,
Bo Guo,
Chen Huang,
Jiangfang Lian

Affiliations

Yongfei Song: Ningbo Institute of Innovation for Combined Medicine and Engineering
Xiaofei Wang: Biomedical Experimental Center
Dongdong Tong: Department of Cell Biology and Genetics
Xiaoyan Huang: Ningbo Institute of Innovation for Combined Medicine and Engineering
Xiaojun Jin: Ningbo Institute of Innovation for Combined Medicine and Engineering
Chuanjing Zhang: Ningbo Institute of Innovation for Combined Medicine and Engineering
Jianhui Liu: Department of Cardiology
Bo Guo: Department of Cell Biology and Genetics
Chen Huang: Ningbo Institute of Innovation for Combined Medicine and Engineering
Jiangfang Lian: Ningbo Institute of Innovation for Combined Medicine and Engineering

DOI: https://doi.org/10.1155/crp/2349610
Journal volume & issue: Vol. 2025

Abstract

Read online

Conclusion: B2M and C3 have been identified as potential biomarkers for viral myocarditis, providing valuable insights for future investigations into the pathogenesis of COVID-19-associated myocarditis.

Published in Cardiology Research and Practice

ISSN: 2090-8016 (Print); 2090-0597 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://onlinelibrary.wiley.com/journal/2804

About the journal